Related Experiment Video
Updated: Feb 15, 2026
09:02
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
7.9K
Immunotherapy for Chronic Hepatitis B Virus Infection.
Antonio Bertoletti1,2, Nina Le Bert1,2
1Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore.
Gut and Liver
|January 11, 2018
Summary
Curative therapies for chronic hepatitis B virus (HBV) infection are still needed. Immune cell therapy offers a promising approach to control HBV replication and potentially achieve a functional cure.
Area of Science:
- Hepatology
- Immunology
- Virology
Background:
- Current direct antiviral therapies for chronic hepatitis B virus (HBV) infection control viral replication but require lifelong administration due to frequent viral rebound.
- Interferon-based immune modulation is effective only in a subset of patients with chronic HBV infection.
- Curative therapies for chronic HBV infection remain a significant unmet medical need.
Purpose of the Study:
- To review the development of immune cell therapy for chronic hepatitis B virus (HBV) infection.
- To highlight the potential antiviral efficacy and toxicities of immune cell therapies in different patient groups.
- To identify chronic hepatitis B patient populations that would most benefit from immune interventions.
Main Methods:
- Review of existing literature on immune cell therapy for HBV.
- Analysis of potential antiviral mechanisms and associated toxicities.
- Discussion of patient stratification for therapeutic immune interventions.
Main Results:
- Immune cell therapy presents a potential strategy for HBV elimination or sustained low-level replication control.
- Different patient groups may respond differently to immune cell therapies, with varying efficacy and toxicity profiles.
- Identifying optimal patient populations is crucial for successful immune-based interventions.
Conclusions:
- Immune cell therapy holds promise for achieving a functional cure in chronic hepatitis B virus (HBV) infection.
- Careful patient selection is essential to maximize therapeutic benefits and minimize risks.
- Further research is needed to optimize immune cell therapies for widespread clinical application in HBV treatment.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
00:50What are Viruses?
128.5K
Overview
128.5K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
282
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
282
01:21Hepatic Portal System
6.4K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.4K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
256
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
256
01:23Chronic Pharyngitis
12.6K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
12.6K